A phase II study has found that adding a postinduction course of blinatumomab (Blincyto) to chemotherapy is safe and highly effective for treating an aggressive form of acute lymphoblastic leukemia (ALL) in infants. The study, conducted by researchers from the Princess Máxima Center for Pediatric Oncology in Utrecht, the Netherlands, found that the regimen, which
A randomized trial from Italy showed that two types of bariatric-metabolic surgery are more effective than lifestyle modification plus best medical care in treating non-alcoholic steatohepatitis (NASH). In the study, over 200 patients with obesity and biopsy-confirmed NASH who completed the trial were assigned to Roux-en-Y and sleeve gastrectomy. The primary endpoint of histological resolution
Xavier Becerra, former HHS Secretary, testified before Congress and was questioned about the implementation of the No Surprises Act. The Act was passed in 2020 to prevent surprise medical bills and ensure fair negotiations between insurance companies and healthcare providers. However, there have been many challenges with its implementation. Senator Michael Bennet criticized the implementation
A clinical trial has found that using hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C alongside surgery for locally advanced colorectal cancer (CRC) has significantly reduced the risk of locoregional recurrence. At the end of three years, patients who underwent cytoreduction plus HIPEC with mitomycin C had a 10% increase in locoregional control compared to those